Protocol #:
Approval Date:
TNPRC Only
Projects:
Assigned Vet:
Census Code:
Institutional Animal Care & Use Committee
PROTOCOL for the Use of Live Nonhuman Vertebrates
(other than NHPs) in Research, Teaching or Demonstration
IACUC Office, 1430 Tulane Ave. 8423 New Orleans, LA 70112 504-988-6868
TNPRC IACUC Office, 18703 Three Rivers Road, Covington LA 70343 985-871-6636
Email a copy of this protocol to iacuc@tulane.edu
Date Filed:
Principal Investigator:
Division / Department:
E-mail:
http://tulane.edu/asvpr/iacuc/index.cfm
Position/Title:
Phone:
Lab Phone:
Address/Mailbox:
Co-investigator and/or Tulane contact:
Position/Title:
Division / Department:
Additional Contact Person(s):
Emergency Contact:
Phone:
(required if PI is an outside collaborator at the TNPRC)
E-mail:
Email:
Phone:
TITLE OF PROTOCOL:
List the Title of the grant only if it differs from the protocol title:
FUNDING AGENCY OR SOURCE:
PROJECT START DATE:
DURATION OF PROJECT:
- Please include animal use for the
duration of the entire study. While protocols are approved for three years the committee needs to review the complete
project.
TNPRC ONLY
IS THIS PROTOCOL A SUBCONTRACT OR FEE-FOR-SERVICE?
NO
YES (If the PI of the grant is affiliated with an institution other than TNPRC, “yes” should be indicated.)
IF YES, INDICATE PI OF THE GRANT:
INITIAL PROTOCOL –Proceed to Section III. Species
RENEWAL PROTOCOLS – List protocol number:
V6-2015
Page 1 of 10
Start at Section I. A
SECTION I. RENEWAL PROTOCOLS ONLY
Please enter a brief summary of what has been accomplished thus far so that the continuation efforts described in
this protocol can be better understood. Please include any relevant publications from your study.

SECTION II. ANIMALS CURRENTLY ASSIGNED (animals housed in the animal facility)
Animals are currently in the DCM animal facility. Please note that animals must be transferred with paperwork
using new cage cards when the renewal protocol is approved. Comment if needed:
SECTION III. SPECIES, NUMBER & CATEGORY OF ANIMAL USE
SPECIES
STRAIN
NUMBER
.
.
.
.
.
.
COMMENT:
*USDA
CATEGORY
.
.
.
.
.
.
*http://tulane.edu/asvpr/iacuc/index.cfm for detailed description of each USDA category
IMPORTANT
All questions must be answered in order for the protocol to undergo IACUC review.
Do not refer to or attach passages from grants.
SECTION IV. REGULATORY INFORMATION
A. Please check YES or NO as it applies to the species requested. If you answer YES to a question, you must
provide an explanation and justification.
1. Is this an endangered or threatened species?
No
Yes
2. Is short-term (> 30 minutes; < 12 hours) physical restraint of a conscious animal employed?
No
Yes
3.
Is long-term (12 hours or more) physical restraint of a conscious animal employed?
No
Yes
4.
Will specialized management procedures be required, e.g. specialized caging equipment, restricted or altered
feeding/watering/sanitization schedules, or environmental parameters such as cage size, temperature, lighting
or other fall outside the “Guide for the Care and Use of Laboratory Animals”?
No
Yes
V6-2015
Page 2 of 10
5.
Will you perform more than one major survival surgery on any animal? PLEASE NOTE: major survival
surgery penetrates and exposes a body cavity or produces substantial impairment of physical or physiologic
functions (such as laparotomy, thoracotomy, craniotomy, joint replacement or limb amputation).
No
Yes
6.
Will animals be housed outside of AAALAC-accredited Tulane facilities for over 12 consecutive hours? If
YES, the proposed site must be inspected and approved by the IACUC prior to use. Please list the location
with justification below.
No
Yes
I have read the Policy for Satellite Housing http://tulane.edu/asvpr/iacuc/hsc/sops.cfm and will provide
applicable SOPs. The satellite housing must be approved by the IACUC prior to the start of the study.
7.
Will pain or distress without the use of analgesic or anesthetic agents occur during the course of
experimentation? This is Category E and must be scientifically justified with references.
No
Yes
8.
Will these procedures be filmed, videotaped or photographed for use outside the institution? If so, you must
obtain approval from the Executive Director of Comparative Medicine. (985-871-6285)
No
Yes
9.
Does this protocol include a breeding colony?
No
Yes - Please complete the Breeding Appendix located at http://tulane.edu/asvpr/iacuc/hsc/deadlines.cfm
SECTION V. PERSONNEL HAZARDS
A. Is there potential exposure of humans to chemical hazards, physical hazards, radioactive agents, or
biohazardous agents during the course of animal experimentation?
No
Yes - please respond to the choices below.
1.
2.
3.
4.
Physical
Chemical
Radioactive
Indicate the hazard:
Indicate the hazard:
Indicate the hazard:
Biohazard / Recombinant DNA
Indicate the hazard:
Does this biohazard require IBC approval? http://tulane.edu/asvpr/biosafety/committee/index.cfm
Yes, please provide the IBC#
No
Personnel from the Office of Biosafety or the Office of Environmental Health and Safety may contact you for
additional information or completion of forms.
SECTION VI. NON-TECHNICAL SUMMARY
Using non technical language (lay) that a layperson with no scientific background would understand, provide a
brief summary that describes the nature and purpose of the this study and its potential value to human or animal
health the advancement of knowledge or the betterment of society. Do not use scientific jargon, acronyms or
abbreviations and do not cut and paste from grant applications.
V6-2015
Page 3 of 10

SECTION VII. COMPLETE DESCRIPTION OF ANIMAL USE
A. HYPOTHESES - Please state your hypotheses in this section but do not cut and paste passages from your
grant application. It is recommended that you limit this to approximately 20 lines.

B. DESCRIPTION - Provide a concise description including all steps, in chronological order, the experimental
course of an animal from its entry into the experiment to the endpoint of the study. It is recommended that you
provide a table or tables, which includes the Animal Group Composition, Sampling, Procedures, Drugs,
Compounds and Time points. Please provide a table title reference if using more than one table.

Insert table
C. STANDARD OPERATING PROCEDURES (SOPs)
Procedures may reference an approved TULANE SOP/Policy in lieu of a complete description. Please choose
all of the SOPs that will be used on your study. SOP/policies listed here are available at
http://tulane.edu/asvpr/iacuc/hsc/sops.cfm or contact the IACUC office.
If there is no approved SOP then a complete description must be included in VII.B.
.
.
.
.
.
.
.
.
.
.
D. PROPOSED TREATMENTS
ALLEVIATION OF PAIN AND DISTRESS: Describe the use of analgesics, anesthetics, and tranquilizing
drugs to minimize discomfort, distress, pain or injury. The list below contains some common drugs and doses and
must be checked if they will be administered in this protocol.
MOUSE AND RAT
DRUG
DOSE
ROUTE
Preanesthetic
Atropine
0.05 mg/kg
IM/SC
Anesthetic Drugs
Ketamine/Xylazine
80-110/5-10 mg/kg
IM/IP
Pentobarbital
50-80 mg/kg
IP
Isoflurane gas
1-5% in oxygen, to effect
Inhalation
Analgesic Drugs
Buprenorphine
0.05-0.1 mg/kg
IM/SC/IP
Caroprofen
1-2 mg/kg
SC/PO
Meloxicam
1-2 mg/kg
SC/PO
Local anesthetics/analgesics (can be combined in same syringe)
Lidocaine
0.5%, maximum dose 7
SC/intramg/kg
incisional
V6-2015
Page 4 of 10
FREQUENCY
Prior to anesthesia
As needed
As needed
Continuous
BID-TID
BID
SID
Fast onset, but short duration (1 hour)
Bupivicaine
0.25%, maximum dose 8
SC/intramg/kg
incisional
OTHER analgesics, anesthetics, and tranquilizing drugs that will be used:
Slow onset, but long duration (4-8 hours)
RABBIT
DRUG
Preanesthetic Drugs
Glycopyrrolate
Sedative Drugs
DOSE
ROUTE
FREQUENCY
0.01 mg/kg
IM/SQ
Prior to anesthesia
1/0.02 mg/kg
IM/SQ
Acepromazine/Buprenorphine
Ketamine/Diazepam
20-25/1-3 mg/kg
IM/SQ
Anesthetic Drugs
Isoflurane gas
1-5% in oxygen, to effect
Inhalation
Ketamine/Xylazine
20-35/1-3 mg/kg
IM
Analgesic Drugs
Buprenorphine
0.01-0.05 mg/kg
IM/SQ
Meloxicam
0.1-0.2 mg/kg
IM/PO
OTHER analgesics, anesthetics, and tranquilizing drugs that will be used:
As needed
As needed
Continuous
As needed
BID
Once daily
PIG
DRUG
DOSE
ROUTE
Preanesthetic
Atropine
0.04 mg/kg
IM/SC
Anesthetic Drugs
Tiletamine4-6/2-3 mg/kg
IM/IV
Zolazepam/Xylazine
Pentobarbital
40-50 mg/kg
IV
Isoflurane gas
1-5% in oxygen, to effect Inhalation
Analgesic Drugs
Buprenorphine
0.05-0.1 mg/kg
IM
Local anesthetics/analgesics (can be mixed and combined in same syringe)
Lidocaine
0.5%, maximum dose 7
SC/IT/intramg/kg
incisional
Bupivicaine
0.25%, maximum dose 8
SC/IT/intramg/kg
incisional
OTHER analgesics, anesthetics, and tranquilizing drugs that will be used:
FREQUENCY
Prior to anesthesia
As needed
As needed
Continuous
BID
Fast onset, but short duration (1 hour)
Slow onset, but long duration (4-8 hours)
List all drugs, agents, compounds, and substances that are introduced to the animals throughout the study
period as described in the complete description.
SELECT TYPE
.
.
.
.
V6-2015
NAME
DOSE
Page 5 of 10
ROUTE
.
IN VIVO RADIONUCLIDE(s)
INSECT VECTORS
VOLUME
NUMBER
MODE
E. VETERINARY CARE
Routine care as specified in the standard operating procedures
 Division of Veterinary Medicine (985-871-6266) http://www.tnprc.tulane.edu/index.shtml
 Department of Comparative Medicine (504-988-5211) http://tulane.edu/asvpr/dcm/index.cfm
Special care. Provide a plan of action including phone numbers of essential personnel.

F. ADVERSE EFFECTS /CLINICAL ENDPOINTS
Please list any adverse effects or reactions that have been documented or could be expected from the use of the test
article (drug, inoculum. antibody, other material or devices) animal phenotype or procedure during the study. If
none are expected, please state that and provide information that supports the statement.

Please list what treatment plan(s) will be employed in response to such should they be noted during the course of
this research.

G. ENDPOINTS
To review the Policy of Humane Experimental Endpoints in Rodent Research, please click on this link:
http://tulane.edu/asvpr/iacuc/hsc/sops.cfm
The Policy of Humane Experimental Endpoints in Rodent Research is acceptable for this study.
The endpoints for this study are time based and noted on the Experimental Design Section VII.B.
However, if an animal’s physical condition deteriorates the Policy of Humane Experimental Endpoints in
Rodent Research is acceptable for this study.

There is NO ENDPOINT to this study other than the approved study period and euthanasia is not required.
However, if an animal’s physical condition deteriorates the Policy of Humane Experimental Endpoints in
Rodent Research is acceptable for this study.

I choose not to use the Policy of Humane Experimental Endpoints in Rodent Research - Please list the
criteria to use to determine when euthanasia will be performed.

H. EUTHANASIA METHOD
Indicate the method to be used; include dosage and route of administration for each species indicated.

Is the method listed above consistent with the recommendation of the AVMA Guidelines on Euthanasia?
http://www.avma.org/issues/animal_welfare/euthanasia.pdf
YES, the method listed above is consistent with the recommendation of the AVMA Guidelines on
Euthanasia.
V6-2015
Page 6 of 10
NO, it is not consistent. Please provide justification (supported with references) for not following the
recommendation:
SECTION VIII. ANIMAL USE JUSTIFICATION
A. RATIONALE FOR ANIMAL USE. It must include the reasons why non-animal models cannot be used.

B. APPROPRIATENESS OF THE SPECIES SELECTED (Please address if preliminary studies have been
conducted using other species or lower life forms.)

C. ANIMAL NUMBER JUSTIFICATION
Please identify one or more of the approaches listed below used to justify the number of proposed animals for this
study and provide an explanation.
Citation of previous research, with sufficient information provided to indicate that the previous research is
similar enough in concept and methodology to make it reasonable to use similar sample sizes in the
proposed research project.
Explanation
Statistical analysis- if numbers are chosen with the intent of obtaining statistically significant differences,
the most objective tool is usually a power analysis to determine sample size. When groups are compared,
the goal of conducting a power analysis is to determine the appropriate number of animals per group to
ensure detection of a significant difference.
Explanation
Pilot study- the following information must be included:
 Main outcome measure being evaluated (e.g. reduction in tumor size)
 The definition of success (e.g., a 50% reduction in tumor size in 3 animals) that would indicate
that the study should be followed up by a full study.
Explanation
Teaching /Training
Explanation

Is your study a Category D or E?
No - Proceed to Section X.
Yes - Please complete Section IX.
SECTION IX. ALTERNATIVES TO PAINFUL AND DISTRESSFUL PROCEDURES
As required by Policy 12 of the Animal Welfare Act, “the IACUC is required to assure that the principal
investigator has considered alternatives to procedures that may cause more than momentary or slight pain or
distress” and “that the PI has provided a written narrative description of the methods and sources, such as the
Animal Welfare Information Center, Biological Abstracts, Index Medicus, PubMed, and the Current Research
V6-2015
Page 7 of 10
Information Service.” Here is a link to the databases that you have access to at Tulane
http://libguides.tulane.edu/Animal_Welfare
Alternatives are defined as new methods that refine existing usage by minimizing animals’ distress such as the
use of analgesics, reduce animal usage such as the use of certain experimental designs, or replace whole animal
tests with other procedures such as the use of in vitro analyses.
Database
Used
Date of
search
Period
covered by
search
Keywords used
Number of
relevant
references
Were
alternatives
found
If alternatives were found, justify why they are not being used.

Additional relevant sources may include scientific meetings, scientific discussion, consultation with veterinary
staff and federal law or other legal guidelines. Please list below.

SECTION X. ENVIRONMENTAL ENHANCEMENT
Tulane University houses all rodents, guinea pigs and rabbits according to Tulane standard operating procedures
(SOPs). In addition, all animals are group housed, when compatible, and provided with various nesting materials
and/or cage manipulanda, when appropriate.
SELECT HOUSING/ENRICHMENT CATEGORY PER SPECIES
SPECIES
.
.
.
.
HOUSING / ENRICHMENT
.
.
.
.
*EXPLANATION / JUSTIFICATION
Standard Enrichment at Tulane University
Mice: Group Housing, Nesting Material
Rats: Group Housing, Hides/Tunnels
Dogs: Group Housing, Resting Boards, Toys, Human Interaction, DCM Dog Exercise Program
Cats: Group Housing, Resting Boards, Toys, Human Interaction
Pigs: Group Housing, Toys, Human Interaction
Rabbits: Group Housing, Toys, Feed Supplement, Human Interaction
If you need additional information or would like to request additional options for enrichment (see below) please
contact: DCM Downtown – 504-988-5211 DCM Uptown 865-6717
TNPRC - Small Animal Veterinarian at 985-871-6496 and/or Small Animal Supervisor at 985-871-6348
Options for Additional/Alternative Enrichment
Mice: Toys, Feed Supplement, Hides/Tunnels
Rats: Toys, Feed Supplement, Human Interaction, Nesting Material
Dogs: Feed Supplement
Cats: Feed Supplement
Pigs: Feed Supplement, Music
Rabbits: Nesting Material, Music
V6-2015
Page 8 of 10
SECTION XI. PERSONNEL
Provide a listing of all personnel who will have direct contact with animals involved with the proposed
experimentation. Do not list veterinary medicine staff involved with the daily husbandry. You must list each
person’s role on the project. All individuals must be appropriately qualified and trained in the proposed animal
care and use.
NAME/ TITLE
SPECIFIC ROLE ON PROJECT
examples would be surgery, euthanasia,
breeding colony maintenance, blood
collection, behavioral studies or basic
animal handling such as weighing or ear
tagging.
TRAINING
List training or experience for roles or indicate
that additional training is needed. If additional
training is needed please state who will conduct
the training and their years of experience.
Outside Persons who will conduct procedures Persons who will conduct any procedure on-site must have
completed the training and occupational health programs prior to the start of the project.
DCM Downtown – 504-988-5211 DCM Uptown – 504-865-6717
TNPRC - Please contact the Occupational Nurse at 985-871-6596 to complete the necessary forms.
NAME/
TITLE
AFFLIATION
SPECIFIC ROLE ON PROJECT
-i.e. surgery, tissue collection,
euthanasia,
TRAINING - List training for role or
indicate that additional training is
needed.
RISK ASSESSMENT AND HISTORY FORM (RAHF): All faculty, staff, and students who handle animals as
a part of this protocol must participate in the Animal Handlers Health Surveillance Program to include the
completion of the RAHF available at http://tulane.edu/oehs/ocsafety/animalhealthprogram.cfm
SECTION XII. FACILITIES
List all rooms outside of the DCM Animal Facilities used for animal experimentation, demonstration, drug storage
or housing. All animal rooms must be inspected and approved by the IACUC prior to animal use. Please contact
the IACUC office for information on approved rooms. Please select the room use from the drop-down box (more
than one ‘use’ may be selected for each room)
BUILDING
ROOM #
USE
USE
.
.
.
.
.
.
.
.
.
.
.
.
If use for a room is not in the above drop box listing, please describe:
V6-2015
Page 9 of 10
USE
.
.
.
.
SECTION XII. PRINCIPAL INVESTIGATOR CERTIFICATIONS
1.
2.
3.
4.
5.
6.
7.
8.
I certify that the animal care and use described in this protocol is exactly as described in the funding
application (if applicable) for this protocol.
I certify that I have determined that the research proposed herein is not unnecessarily duplicative of
previously reported research.
I certify that all individuals working on this protocol are participating in the Tulane University Occupational
Health and Safety Program.
I certify that the individuals listed in Personnel, if noted to do animal work, are authorized to conduct
procedures involving animals under this proposal, have received training in: the biology, handling, and care
of this species: aseptic surgical methods and techniques (if necessary): the concept, availability, and use of
research or testing methods that limit the use of animals or minimize distress: the proper use of anesthetics,
analgesic, and tranquilizers (if necessary): and procedures for reporting animal welfare concerns.
For all USDA Classification D and E protocols I certify that I have reviewed the pertinent scientific literature
and have found no valid alternative to any procedures described herein which may cause more than
momentary pain or distress, whether it is relieved or not.
I certify that I will obtain approval from the IACUC before initiating any changes in this study.
I certify that I will notify the IACUC regarding any unexpected study results that impact the animals. Any
unanticipated pain or distress, morbidity, or mortality will be reported to the attending veterinarian and the
IACUC.
I certify that I am familiar with and will comply with all pertinent institutional, state, and federal rules and
policies.
I have read the assurances and I understand that failure to comply with these assurances may result in suspension or
termination of this animal activity and the filing of a report of non-compliance with this Institution’s IO and
appropriate governing agencies.
Principal Investigator
V6-2015
Date
Page 10 of 10